Efalizumab, a novel potent regulator of T cells, is a humanized LFA-1 alpha subunit (CD11a) monoclonal antibody. Efalizumab has inhibitory effects on T cell activation, skin T cell transport, and T cell adhesion to keratinocytes, and can be used to study pla
CAS Number:
[214745-43-4]
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted